Analysts Estimate Report : What to Look Out for Halozyme ...
Earnings results for Halozyme Therapeutics (NASDAQ:HALO) Halozyme Therapeutics last released its earnings results on August 9th, 2021. The biopharmaceutical company reported $0.62 EPS for the quarter, beating the consensus estimate of $0.43 by $0.19.
